Peter B. Heifetz, Ph.D.

Peter Heifetz serves as the Chief Executive Officer of OrPro Therapeutics, Inc., a San Diego company focused on addressing unmet medical needs with a cell-protective biologic drug platform. As the Founder and Principal Consultant at Heifetz BioConsulting, Peter specializes in enhancing value in the CleanTech and Life Sciences sectors through strategic integration. Previous roles include Chief Scientific Officer at Rincon Pharmaceuticals, contributing to R&D and product development, and serving on the Advisory Board at ERA Biotech. Peter's extensive experience in research and development also includes positions at Diversa Corporation, Syngenta Corporation, and Novartis Research Foundation. Educational credentials include a BS, MS, and PhD in Biology, Biochemical Engineering, and Genetics from Duke University.